Inventor · disambiguated record
Philip Lienau
Also filed as: LIENAU PHILIP · LIENAU PHILIP ALEXANDER
77 granted patents·49 pending applications·223 citations·filing 2003–2025
98Inventor score
Top patents by PatentIndex Score
126 records- 0196US9549932B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2016·Granted Jan 24, 2017·26 cites·30 claims
- 0294US11773070B2DihydrooxadiazinonesBAYER AG·Filed 2022·Granted Oct 3, 2023·2 cites·9 claims
- 0394US9284319B2Heterocyclyl aminoimidazopyridazinesEIS KNUT·Filed 2012·Granted Mar 15, 2016·28 cites·5 claims
- 0493US11492358B1Macrocyclic indole derivativesBAYER AG·Filed 2021·Granted Nov 8, 2022·3 cites·18 claims
- 0593US10729680B25-substituted 2-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2017·Granted Aug 4, 2020·10 cites·14 claims
- 0692US10981932B2Macrocyclic indole derivativesBAYER AG·Filed 2017·Granted Apr 20, 2021·9 cites·17 claims
- 0792US9320737B2Substituted imidazopyridazinesBAYER IP GMBH·Filed 2012·Granted Apr 26, 2016·27 cites·12 claims
- 0890US12258323B2DihydrooxadiazinonesBAYER AG·Filed 2022·Granted Mar 25, 2025·1 cites·15 claims
- 0990US11427553B2DihydrooxadiazinonesBAYER AG·Filed 2018·Granted Aug 30, 2022·4 cites·11 claims
- 1090US9730929B2Substituted aminoimidazopyridazinesEIS KNUT·Filed 2012·Granted Aug 15, 2017·25 cites·14 claims
- 1189US9993484B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2015·Granted Jun 12, 2018·4 cites·9 claims
- 1288US11142522B2Compounds, compositions and methods for cancer treatmentBROAD INST INC·Filed 2018·Granted Oct 12, 2021·4 cites·16 claims
- 1385US11529356B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2020·Granted Dec 20, 2022·1 cites·20 claims
- 1485US10772893B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2018·Granted Sep 15, 2020·2 cites·12 claims
- 1583US8916557B2Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-aminesLücking Ulrich·Filed 2012·Granted Dec 23, 2014·4 cites·15 claims
- 1683US2024366620A1Compounds, compositions and methods for cancer patient stratification and cancer treatmentBayer Pharma AG·Filed 2024·Application pending·0 cites
- 1781US9340528B2Substituted aminoquinoxalines as tyrosine threonine kinase inhibitorsBADER BENJAMIN·Filed 2010·Granted May 17, 2016·12 cites·6 claims
- 1881US8735412B2Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicineLücking Ulrich·Filed 2009·Granted May 27, 2014·6 cites·19 claims
- 1980US9670202B2Substituted triazolopyridinesBayer Pharma AG·Filed 2014·Granted Jun 6, 2017·2 cites·16 claims
- 2080US9382255B2Substituted pyrrolopyrimidinylamino-benzothiazolones as MKNK kinase inhibitorsBayer Pharma AG·Filed 2013·Granted Jul 5, 2016·3 cites·9 claims
- 2179US10966986B2Compounds, compositions and methods for cancer patient stratification and cancer treatmentBayer Pharma AG·Filed 2017·Granted Apr 6, 2021·1 cites·8 claims
- 2279US9133171B2Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Sep 15, 2015·5 cites·13 claims
- 2378US10266548B2Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2017·Granted Apr 23, 2019·2 cites·2 claims
- 2478US10214542B2Modified macrocyclic compoundsBayer Pharma AG·Filed 2016·Granted Feb 26, 2019·2 cites·27 claims
- 2578US8802686B2Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicineLücking Ulrich·Filed 2009·Granted Aug 12, 2014·4 cites·12 claims
- 2677US10717749B2Macrocyclic sulfondiimine compoundsBayer Pharma AG·Filed 2016·Granted Jul 21, 2020·2 cites·17 claims
- 2777US10428063B24H-pyrrolo[3,2-C]pyridin-4-one derivativesBayer Pharma AG·Filed 2016·Granted Oct 1, 2019·3 cites·15 claims
- 2875US11254690B2PTEFb inhibiting macrocyclic compoundsBAYER AG·Filed 2018·Granted Feb 22, 2022·1 cites·22 claims
- 2975US11242356B2PTEFb inhibiting macrocyclic compoundsBAYER AG·Filed 2018·Granted Feb 8, 2022·1 cites·22 claims
- 3075US9669034B24-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Jun 6, 2017·2 cites·12 claims
- 3175US9409889B2Amino-substituted imidazopyridazinesBayer Pharma AG·Filed 2013·Granted Aug 9, 2016·3 cites·9 claims
- 3275US9255100B2Substituted imidazopyridazinesKLAR ULRICH·Filed 2011·Granted Feb 9, 2016·3 cites·14 claims
- 3374US12053476B2Compounds, compositions and methods for cancer patient stratification and cancer treatmentBayer Pharma AG·Filed 2021·Granted Aug 6, 2024·0 cites·6 claims
- 3474US9499547B2Amino-substituted imidazopyridazinesEIS KNUT·Filed 2012·Granted Nov 22, 2016·3 cites·16 claims
- 3574US2024182452A16-phenyl-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancerBAYER AG·Filed 2023·Application pending·0 cites
- 3673US9963464B2Macrocyclic compoundsBayer Pharma AG·Filed 2015·Granted May 8, 2018·2 cites·29 claims
- 3773US9877954B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2017·Granted Jan 30, 2018·1 cites·15 claims
- 3872US9540392B2ThienopyrimidinesBayer Pharma AG·Filed 2013·Granted Jan 10, 2017·2 cites·10 claims
- 3971US8642611B2Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameHARTUNG INGO·Filed 2008·Granted Feb 4, 2014·2 cites·15 claims
- 4070US9650340B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2013·Granted May 16, 2017·1 cites·9 claims
- 4170US7795264B2Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameBAYER SCHERING PHARMA AG·Filed 2007·Granted Sep 14, 2010·1 cites·23 claims
- 4269US9499492B24-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine groupBayer Pharma AG·Filed 2013·Granted Nov 22, 2016·1 cites·14 claims
- 4367US11691986B2PTEFB inhibiting macrocyclic compoundsBAYER AG·Filed 2021·Granted Jul 4, 2023·0 cites·20 claims
- 4467US9108926B2Disubstituted 5-fluoro-pyrimidinesLücking Ulrich·Filed 2012·Granted Aug 18, 2015·1 cites·11 claims
- 4566US10487092B2Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitorsBayer Pharma AG·Filed 2015·Granted Nov 26, 2019·1 cites·22 claims
- 4666US9790189B2Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine groupBayer Pharma AG·Filed 2015·Granted Oct 17, 2017·1 cites·26 claims
- 4766US9199999B2Substituted imidazopyrazinesKLAR ULRICH·Filed 2011·Granted Dec 1, 2015·1 cites·5 claims
- 4865US12427153B21,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseasesBAYER AG·Filed 2021·Granted Sep 30, 2025·0 cites·8 claims
- 4965US9284317B2Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitorsKOPPITZ MARCUS·Filed 2011·Granted Mar 15, 2016·1 cites·10 claims
- 5065US9212184B26-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitorsKOPPITZ MARCUS·Filed 2011·Granted Dec 15, 2015·1 cites·10 claims
Showing the top 50 of 126 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Philip Lienau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →